Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schroeder Theodore R
Relationship:   Director
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   22,996    

Indirect Shares

   117,489      
Direct Value   $380,610    

Indirect Value

   $46,267      
Total Shares   140,485      
Total Value   $426,877      


Collegium Pharmaceutical, Inc $375,889 Nabriva Therapeutics AG $4,721 Collegium Pharmaceutical, Inc $375,889 Nabriva Therapeutics AG $4,721
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   -1.0   
   0.0   
     Percentage Gain/Loss :
   -100.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cadence Pharmaceuticals Inc CADX President, CEO, Director 2014-03-19 0 2014-03-19 0    Premium*  
            Hyperion Therapeutics Inc HPTX Director 2015-05-07 0 2014-08-13 0    Premium*  
            Collegium Pharmaceutical, Inc COLL Director 2020-05-20 11,007 2018-05-24 0    Premium*  
            Nabriva Therapeutics AG NBRV Director 2023-01-29 11,989 2019-08-27 117,489    Premium*  
* Premium Members only  

Records found :    90         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CADX Cadence Pharmaceuticals I... President, CEOOfficer   •       –      –    2006-10-24 3 IO $0.00 $0 D/D 0 500,000 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2008-02-20 4 A $5.34 $58,740 I/I 11,000 511,000 0 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2009-10-16 4 AS $10.72 $214,376 I/I (20,000) 491,000 0 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2009-12-31 4 AS $9.76 $191,866 I/I (19,657) 471,343 0 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2010-01-04 4 AS $9.80 $101,363 I/I (10,343) 461,000 0 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2010-03-31 4 AS $9.30 $260,330 I/I (28,003) 432,997 0 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2010-04-01 4 AS $9.03 $198,626 I/I (21,997) 411,000 0 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2010-06-30 4 AS $7.00 $287,250 I/I (41,021) 369,979 0 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2010-07-01 4 AS $6.95 $62,401 I/I (8,979) 361,000 0 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2010-09-30 4 AS $8.35 $339,691 I/I (40,703) 320,297 0 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2010-10-01 4 AS $8.35 $77,670 I/I (9,297) 311,000 0 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2010-11-11 5 GD $0.00 $0 I/I 19,500 291,500 0 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2011-05-17 4 B $7.48 $119,626 I/I 16,000 307,500 2.66 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2011-11-02 4 D $5.72 $41,962 D/D (7,336) 12,664 0 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2011-11-02 4 OE $0.00 $0 D/D 20,000 20,000 0 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2014-03-19 4 D $14.00 $4,305,000 I/I (307,500) 0 0 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2014-03-19 4 D $14.00 $177,296 D/D (12,664) 0 0 -
COLL Collegium Pharmaceutical,... Director   –       •      –    2018-05-24 4 A $0.00 $0 D/D 2,253 2,253 0 -
COLL Collegium Pharmaceutical,... Director   –       •      –    2019-04-25 4 A $0.00 $0 D/D 4,707 6,960 0 -
COLL Collegium Pharmaceutical,... Director   –       •      –    2020-05-20 4 A $0.00 $0 D/D 4,047 11,007 0 -
HPTX Hyperion Therapeutics Inc Director   –       •      –    2014-08-13 4 A $0.00 $0 D/D 3,700 3,700 0 -
HPTX Hyperion Therapeutics Inc Director   –       •      –    2015-05-07 4 D $46.00 $141,818 D/D (3,083) 0 0 -
HPTX Hyperion Therapeutics Inc Director   –       •      –    2015-05-07 4 D $46.00 $28,382 D/D (617) 0 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2019-07-25 4 A $0.00 $0 I/I 6,748 67,489 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2019-08-27 4 B $1.79 $89,500 I/I 50,000 117,489 2.66 -
  90  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us